FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
||||||||||||||
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Data Storage Corp [ DTST ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 01/02/2024 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
---|---|---|---|---|---|---|---|---|---|---|
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 01/02/2024 | A | 17,065(1) | A | $0 | 357,710 | D | |||
Common Stock | 16,667 | I | Piluso Family Associates(2) | |||||||
Common Stock | 65,083 | I | Piluso Family Associates LLC(3) | |||||||
Common Stock | 230,116 | I | The Lasata 2012 Trust dated 5/4/12(4) | |||||||
Common Stock | 230,116 | I | The Bella Vita 2012 Trust dated 5/4/12(5) |
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options(6) | $3.22 | 01/02/2024 | A | 15,528 | 01/02/2025 | 01/01/2029 | Common Stock | 15,528 | $0 | 15,528 | D |
Explanation of Responses: |
1. Represents the shares of the Issuer's common stock underlying a restricted stock unit ("RSU") grant to the Reporting Person on January 2, 2024, which RSUs vest over a three-year period, in three equal annual installments starting on January 2, 2025; January 2, 2026; and January 2, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. |
2. The Reporting Person is a Managing Member of Piluso Family Associates, together with his spouse. |
3. The Reporting Person is a Managing Member of of Piluso Family Associates LLC, together with his spouse. |
4. The Reporting Person's spouse is the beneficiary of The Lasata 2012 Trust dated 5/4/12 ("The Lasata Trust") and the Reporting Person's spouse, together with Lawrence Maglione, a director of the Issuer, are the co-trustees of the Lasata Trust. |
5. The Reporting Person is the beneficiary of The Bella Vita 2012 Trust dated 5/4/12 ("The Bella Vita Trust") and the Reporting Person, together with his spouse, are the co-trustees thereof. |
6. These options vest and become exercisable in three equal annual installments over the three-year period measured from January 2, 2024, vesting commencing on January 2, 2025, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant. |
/s/ Charles M. Piluso | 01/04/2024 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.